Skip to content

AFFILIATES:

  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
Menu
  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
Brookline Capital Markets
  • OUR STORY
  • ABOUT THE FIRM
  • TEAM
  • TRANSACTIONS
  • NEWS
  • EQUITY RESEARCH
  • LEGAL DISCLOSURES
  • CONTACT
Menu
  • OUR STORY
  • ABOUT THE FIRM
  • TEAM
  • TRANSACTIONS
  • NEWS
  • EQUITY RESEARCH
  • LEGAL DISCLOSURES
  • CONTACT

2022

Circulogene Convertible Note – June 2022

Read More Circulogene Convertible Note – June 2022Continue

Aquestive Capital Markets Advisory – April 2022

Read More Aquestive Capital Markets Advisory – April 2022Continue

Outlook Therapeutics® Enters Definitive Agreement for $31.8 Million Unsecured Convertible Promissory Note

Read More Outlook Therapeutics® Enters Definitive Agreement for $31.8 Million Unsecured Convertible Promissory NoteContinue

IceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Read More IceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq RulesContinue

SAB Biotherapeutics Announces $7.9 Million Private Placement of Common Stock

Read More SAB Biotherapeutics Announces $7.9 Million Private Placement of Common StockContinue

X4 Pharmaceuticals Prices $65.0 Million Public Offering

Read More X4 Pharmaceuticals Prices $65.0 Million Public OfferingContinue

CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price

Read More CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing PriceContinue

AGBA ACQUISITION LIMITED COMPLETES BUSINESS COMBINATION WITH TAG HOLDINGS LIMITED

Read More AGBA ACQUISITION LIMITED COMPLETES BUSINESS COMBINATION WITH TAG HOLDINGS LIMITEDContinue

Ainos Announces Pricing of $3.3 Million Public Offering, Uplisting to NASDAQ, and Reverse Stock Split

Read More Ainos Announces Pricing of $3.3 Million Public Offering, Uplisting to NASDAQ, and Reverse Stock SplitContinue

Outlook

Read More OutlookContinue

Page navigation

1 2 3 … 5 Next PageNext

HEADQUARTERS

Brookline Capital Markets

600 Lexington Avenue, 30th Floor
New York, New York 10022
(646) 603-6716

Linkedin

LINKS

  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
Securities Offered Through Arcadia Securities, LLC – Member FINRA/SIPC

FINRA BROKER CHECK

Arcadia Securities LLC Form CRS

Arcadia Securities LLC Reg BI

Order routing information can be accessed through the following link by inputting Arcadia Securities: https://www.orderroutingdisclosure.com/.

© 2022 Brookline Capital Markets. All rights reserved

© 2021 Brookline Capital Markets. All rights reserved